Myomo, Inc. (NYSEAMERICAN:MYO - Get Free Report) Director Thomas F. Kirk acquired 7,400 shares of the company's stock in a transaction on Thursday, March 13th. The shares were bought at an average cost of $5.00 per share, with a total value of $37,000.00. Following the acquisition, the director now directly owns 255,933 shares in the company, valued at approximately $1,279,665. The trade was a 2.98 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website.
Myomo Stock Up 2.4 %
Shares of NYSEAMERICAN:MYO opened at $5.19 on Friday. Myomo, Inc. has a 12 month low of $2.51 and a 12 month high of $7.17. The stock has a market capitalization of $157.00 million, a P/E ratio of -22.57 and a beta of 1.68.
Institutional Trading of Myomo
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Barclays PLC purchased a new stake in Myomo in the 3rd quarter worth about $36,000. Jane Street Group LLC purchased a new stake in Myomo in the 3rd quarter worth about $65,000. GSA Capital Partners LLP raised its position in Myomo by 60.8% in the 3rd quarter. GSA Capital Partners LLP now owns 103,342 shares of the company's stock worth $414,000 after purchasing an additional 39,085 shares during the period. Calamos Advisors LLC purchased a new stake in Myomo in the 4th quarter worth about $189,000. Finally, Stonepine Capital Management LLC purchased a new stake in Myomo in the 3rd quarter worth about $401,000. 44.99% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
Several research analysts have commented on the stock. Alliance Global Partners reissued a "buy" rating on shares of Myomo in a report on Tuesday. HC Wainwright increased their price target on shares of Myomo from $7.50 to $9.50 and gave the company a "buy" rating in a report on Wednesday. Finally, Craig Hallum increased their price target on shares of Myomo from $9.00 to $11.00 and gave the company a "buy" rating in a report on Tuesday. Five research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, Myomo currently has an average rating of "Buy" and an average price target of $9.25.
Get Our Latest Stock Report on MYO
Myomo Company Profile
(
Get Free Report)
Myomo, Inc, a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to contact@insidertrades.com.
